Dark | Light
# Alpine Immune Sciences, Inc. Common Stock (ALPN)

Alpine Immune Sciences (ALPN) stock hits a 1-year high driven by positive Povetacicept trial data and insider buys, despite near 52-week low market dominance. Recent social posts highlight potential partnerships and license deals.

### About Alpine Immune Sciences, Inc. Common Stock
Alpine Immune Sciences, Inc. is a healthcare company focused on immunology.  
Alpine Immune Sciences, Inc. Common Stock uses the ticker $ALPN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Alpine Immune Sciences, Inc. Common Stock (ALPN) market dominance near a 52-week low at [-------].
- Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance is up 114.29% from the previous month.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) creators is up 25% from the previous week.
- Alpine Immune Sciences, Inc. Common Stock (ALPN) engagements is up 1885.99% from the previous week.

### Price: $65
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/close.tsv)  
The stock price has reached a 1-year high, driven by positive clinical trial data for Povetacicept and insider transactions, which are currently outweighing a near 52-week low in market dominance.  

1-Year High: $65 on 2025-02-16  
1-Year Low: $65 on 2025-02-16  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/alt_rank.tsv)  
Alpine Immune Sciences, Inc. Common Stock (ALPN) is currently AltRank #1,666 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] [----]  
[--] Month: [-----] [---]  
[--] Months: [-----] [----]  
[--] Year: [-----] [----]  
1-Year High: [-----] on 2026-02-03  
1-Year Low: [---] on 2025-03-22  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-03-03  
1-Year Low: [--] on 2025-06-05  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [-----] +1,886%  
[--] Month: [------] +55%  
[--] Months: [------] -42%  
[--] Year: [-------] -97%  
1-Year High: [-----] on 2026-01-21  
1-Year Low: [--] on 2026-01-29  

Engagements by network (24h):
Reddit: [--]
X: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] no change  
[--] Month: [--] -15%  
[--] Months: [---] -62%  
[--] Year: [---] -68%  
1-Year High: [--] on 2025-02-19  
1-Year Low: [--] on 2025-12-19  

Mentions by network (24h):
Reddit: [--]
X: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Alpine Immune Sciences, Inc. Common Stock (ALPN) in the last [--] hours which is no change from in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +25%  
[--] Month: [--] -21%  
[--] Months: [--] -46%  
[--] Year: [---] -74%  
1-Year High: [--] on 2025-03-23  
1-Year Low: [--] on 2025-09-06  

The most influential creators that mention Alpine Immune Sciences, Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@HOThomasWPhelps](/creator/twitter/HOThomasWPhelps) | [--]    | [-----]     | [--]     | [--]           |

[View More](/list/creators/$alpn/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 59%  
[--] Month: 100% no change  
[--] Months: 100% +67%  
[--] Year: 100% +50%  
1-Year High: 100% on 2025-06-19  
1-Year Low: 25% on 2025-03-11  

Most Supportive Themes:
- Positive Clinical Trial Data: (50%) Positive clinical trial data for Povetacicept is driving stock price increases.
- Insider Transactions: (30%) Insider transactions are contributing to the stock's upward momentum.
  
Most Critical Themes:
- Near 52-Week Low in Market Dominance: (20%) The stock is experiencing a near 52-week low in market dominance, which could indicate potential downside risk.
  
  
  
### Social Dominance: 0.00046299695281862627%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/social_dominance.tsv)  
Current Value: 0.00046299695281862627%  
Daily Average: 0.00177%  
[--] Week: 0.00053% +0.00004999999999999997%  
[--] Month: 0.0015% +0.0008%  
[--] Months: 0.0015% -0.0002999999999999999%  
[--] Year: 0.0015% -0.0019%  
1-Year High: 0.016% on 2025-02-19  
1-Year Low: 0.0001% on 2025-12-19  
  
  
### Market Dominance: 0.00505%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$alpn/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$alpn/time-series/market_dominance.tsv)  
Current Value: 0.00505%  
Daily Average: 0%  
1-Year High: 0.00678% on 2025-04-08  
1-Year Low: 0.00499% on 2026-01-27  

### Top Alpine Immune Sciences, Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Feel like $VRTX will do biotech investors & $XBI on the whole a solid in coming years in terms of BD $ALPN for $4.9B in cash was back in April [----] Since then it's been crickets mainly license deals such as recent preclinical trispecific T cell engager from WuXi Biologics"  
[X Link](https://x.com/jfais20/status/2022298605520932943) [@jfais20](/creator/x/jfais20) 2026-02-13T13:15Z 11.5K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Alpine Immune Sciences, Inc. Common Stock (ALPN)

Alpine Immune Sciences (ALPN) stock hits a 1-year high driven by positive Povetacicept trial data and insider buys, despite near 52-week low market dominance. Recent social posts highlight potential partnerships and license deals.

About Alpine Immune Sciences, Inc. Common Stock

Alpine Immune Sciences, Inc. is a healthcare company focused on immunology.
Alpine Immune Sciences, Inc. Common Stock uses the ticker $ALPN for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Alpine Immune Sciences, Inc. Common Stock (ALPN) market dominance near a 52-week low at [-------].
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) social dominance is up 114.29% from the previous month.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) creators is up 25% from the previous week.
  • Alpine Immune Sciences, Inc. Common Stock (ALPN) engagements is up 1885.99% from the previous week.

Price: $65

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has reached a 1-year high, driven by positive clinical trial data for Povetacicept and insider transactions, which are currently outweighing a near 52-week low in market dominance.

1-Year High: $65 on 2025-02-16
1-Year Low: $65 on 2025-02-16

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Alpine Immune Sciences, Inc. Common Stock (ALPN) is currently AltRank #1,666 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] [----]
[--] Month: [-----] [---]
[--] Months: [-----] [----]
[--] Year: [-----] [----]
1-Year High: [-----] on 2026-02-03
1-Year Low: [---] on 2025-03-22

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-03-03
1-Year Low: [--] on 2025-06-05

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [-----] +1,886%
[--] Month: [------] +55%
[--] Months: [------] -42%
[--] Year: [-------] -97%
1-Year High: [-----] on 2026-01-21
1-Year Low: [--] on 2026-01-29

Engagements by network (24h): Reddit: [--] X: [---]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] no change
[--] Month: [--] -15%
[--] Months: [---] -62%
[--] Year: [---] -68%
1-Year High: [--] on 2025-02-19
1-Year Low: [--] on 2025-12-19

Mentions by network (24h): Reddit: [--] X: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Alpine Immune Sciences, Inc. Common Stock (ALPN) in the last [--] hours which is no change from in the previous [--] hours Daily Average: [--]
[--] Week: [--] +25%
[--] Month: [--] -21%
[--] Months: [--] -46%
[--] Year: [---] -74%
1-Year High: [--] on 2025-03-23
1-Year Low: [--] on 2025-09-06

The most influential creators that mention Alpine Immune Sciences, Inc. Common Stock in the last [--] hours

Creator Rank Followers Posts Engagements
@HOThomasWPhelps [--] [-----] [--] [--]

View More

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 59%
[--] Month: 100% no change
[--] Months: 100% +67%
[--] Year: 100% +50%
1-Year High: 100% on 2025-06-19
1-Year Low: 25% on 2025-03-11

Most Supportive Themes:

  • Positive Clinical Trial Data: (50%) Positive clinical trial data for Povetacicept is driving stock price increases.
  • Insider Transactions: (30%) Insider transactions are contributing to the stock's upward momentum.

Most Critical Themes:

  • Near 52-Week Low in Market Dominance: (20%) The stock is experiencing a near 52-week low in market dominance, which could indicate potential downside risk.

Social Dominance: 0.00046299695281862627%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00046299695281862627%
Daily Average: 0.00177%
[--] Week: 0.00053% +0.00004999999999999997%
[--] Month: 0.0015% +0.0008%
[--] Months: 0.0015% -0.0002999999999999999%
[--] Year: 0.0015% -0.0019%
1-Year High: 0.016% on 2025-02-19
1-Year Low: 0.0001% on 2025-12-19

Market Dominance: 0.00505%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00505%
Daily Average: 0%
1-Year High: 0.00678% on 2025-04-08
1-Year Low: 0.00499% on 2026-01-27

Top Alpine Immune Sciences, Inc. Common Stock Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"Feel like $VRTX will do biotech investors & $XBI on the whole a solid in coming years in terms of BD $ALPN for $4.9B in cash was back in April [----] Since then it's been crickets mainly license deals such as recent preclinical trispecific T cell engager from WuXi Biologics"
X Link @jfais20 2026-02-13T13:15Z 11.5K followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Alpine Immune Sciences, Inc. Common Stock (ALPN)
/topic/$alpn